169 related articles for article (PubMed ID: 12820363)
1. The tumor metabolome.
Mazurek S; Eigenbrodt E
Anticancer Res; 2003; 23(2A):1149-54. PubMed ID: 12820363
[TBL] [Abstract][Full Text] [Related]
2. Pyruvate kinase type M2: a crossroad in the tumor metabolome.
Mazurek S; Grimm H; Boschek CB; Vaupel P; Eigenbrodt E
Br J Nutr; 2002 Jan; 87 Suppl 1():S23-9. PubMed ID: 11895152
[TBL] [Abstract][Full Text] [Related]
3. Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells.
Mazurek S
Int J Biochem Cell Biol; 2011 Jul; 43(7):969-80. PubMed ID: 20156581
[TBL] [Abstract][Full Text] [Related]
4. Metabolic cooperation between different oncogenes during cell transformation: interaction between activated ras and HPV-16 E7.
Mazurek S; Zwerschke W; Jansen-Dürr P; Eigenbrodt E
Oncogene; 2001 Oct; 20(47):6891-8. PubMed ID: 11687968
[TBL] [Abstract][Full Text] [Related]
5. Pyruvate kinase isoenzyme M2 is a glycolytic sensor differentially regulating cell proliferation, cell size and apoptotic cell death dependent on glucose supply.
Spoden GA; Rostek U; Lechner S; Mitterberger M; Mazurek S; Zwerschke W
Exp Cell Res; 2009 Oct; 315(16):2765-74. PubMed ID: 19563799
[TBL] [Abstract][Full Text] [Related]
6. Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells.
Eigenbrodt E; Reinacher M; Scheefers-Borchel U; Scheefers H; Friis R
Crit Rev Oncog; 1992; 3(1-2):91-115. PubMed ID: 1532331
[TBL] [Abstract][Full Text] [Related]
7. Regulation of pyruvate kinase type M2 by A-Raf: a possible glycolytic stop or go mechanism.
Mazurek S; Drexler HC; Troppmair J; Eigenbrodt E; Rapp UR
Anticancer Res; 2007; 27(6B):3963-71. PubMed ID: 18225557
[TBL] [Abstract][Full Text] [Related]
8. Marker for renal cell carcinoma (RCC): the dimeric form of pyruvate kinase type M2 (Tu M2-PK).
Wechsel HW; Petri E; Bichler KH; Feil G
Anticancer Res; 1999; 19(4A):2583-90. PubMed ID: 10470199
[TBL] [Abstract][Full Text] [Related]
9. Effects of the human papilloma virus HPV-16 E7 oncoprotein on glycolysis and glutaminolysis: role of pyruvate kinase type M2 and the glycolytic-enzyme complex.
Mazurek S; Zwerschke W; Jansen-Dürr P; Eigenbrodt E
Biochem J; 2001 May; 356(Pt 1):247-56. PubMed ID: 11336658
[TBL] [Abstract][Full Text] [Related]
10. Pyruvate kinase type M2: a key regulator within the tumour metabolome and a tool for metabolic profiling of tumours.
Mazurek S
Ernst Schering Found Symp Proc; 2007; (4):99-124. PubMed ID: 18811055
[TBL] [Abstract][Full Text] [Related]
11. Quantification of tumor type M2 pyruvate kinase (Tu M2-PK) in human carcinomas.
Eigenbrodt E; Basenau D; Holthusen S; Mazurek S; Fischer G
Anticancer Res; 1997; 17(4B):3153-6. PubMed ID: 9329624
[TBL] [Abstract][Full Text] [Related]
12. Pyruvate kinase type M2 and its role in tumor growth and spreading.
Mazurek S; Boschek CB; Hugo F; Eigenbrodt E
Semin Cancer Biol; 2005 Aug; 15(4):300-8. PubMed ID: 15908230
[TBL] [Abstract][Full Text] [Related]
13. Pre-analytical problems in the measurement of tumor type pyruvate kinase (tumor M2-PK).
Oremek GM; Gerstmeier F; Sauer-Eppel H; Sapoutzis N; Wechsel HW
Anticancer Res; 2003; 23(2A):1127-30. PubMed ID: 12820359
[TBL] [Abstract][Full Text] [Related]
14. Tumor M2-PK and glutaminolytic enzymes in the metabolic shift of tumor cells.
Mazurek S; Grimm H; Oehmke M; Weisse G; Teigelkamp S; Eigenbrodt E
Anticancer Res; 2000; 20(6D):5151-4. PubMed ID: 11326687
[TBL] [Abstract][Full Text] [Related]
15. The metabolic marker tumour pyruvate kinase type M2 (tumour M2-PK) shows increased expression along the metaplasia-dysplasia-adenocarcinoma sequence in Barrett's oesophagus.
Koss K; Harrison RF; Gregory J; Darnton SJ; Anderson MR; Jankowski JA
J Clin Pathol; 2004 Nov; 57(11):1156-9. PubMed ID: 15509675
[TBL] [Abstract][Full Text] [Related]
16. Quantitative detection of tumor M2-PK in serum and plasma.
Hugo F; Fischer G; Eigenbrodt E
Anticancer Res; 1999; 19(4A):2753-7. PubMed ID: 10470235
[TBL] [Abstract][Full Text] [Related]
17. Tumor-specific pyruvate kinase isoenzyme M2 involved in biochemical strategy of energy generation in neoplastic cells.
Gumińska M; Ignacak J; Kedryna T; Stachurska MB
Acta Biochim Pol; 1997; 44(4):711-24. PubMed ID: 9584851
[TBL] [Abstract][Full Text] [Related]
18. Pyruvate kinase isoenzyme M2 is not of diagnostic relevance as a marker for oral cancer.
Ervens J; Fuchs H; Niemann VT; Hoffmeister B
J Craniomaxillofac Surg; 2008 Mar; 36(2):89-94. PubMed ID: 18243718
[TBL] [Abstract][Full Text] [Related]
19. The pyruvate kinase isoenzyme tumor M2 (Tu M2-PK) as a tumor marker for renal carcinoma.
Oremek GM; Teigelkamp S; Kramer W; Eigenbrodt E; Usadel KH
Anticancer Res; 1999; 19(4A):2599-601. PubMed ID: 10470201
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Pyruvate Kinase isoenzyme tumor (Tu M2-PK) as a tumor marker for cervical carcinoma.
Kaura B; Bagga R; Patel FD
J Obstet Gynaecol Res; 2004 Jun; 30(3):193-6. PubMed ID: 15210041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
